Sorry, you need to enable JavaScript to visit this website.
Pea-sized amount of EPSOLAY cream on a finger of the profile of a hand

Getting started on EPSOLAY cream

3D render of a Galderma CareConnect Card
You may pay as little as $0*

Download your Galderma CareConnect Patient Savings Card and you could pay as little as $0 with commercial insurance or $60 without insurance. If approved, the card can act like an EPSOLAY cream savings coupon to help keep the cost of your prescribed rosacea medication down.

GET SAVINGS CARD

Want to learn more about EPSOLAY cream?

Open brochure
Check out our brochure

Get the basics on EPSOLAY cream and what you can expect when you start treatment.

DOWNLOAD BROCHURE
Open booklet
Talk to a dermatologist about EPSOLAY cream

Download our guide to get helpful tips and conversation starters for talking with your doctor about rosacea and starting EPSOLAY cream.

DOWNLOAD DISCUSSION GUIDE

Support at every step. Get updates straight to your inbox.

Stay Connected

*Certain limitations may apply. Click here for program details.

Galderma CAREConnect Patient Savings Program is only available for commercially insured or uninsured patients. Patients who are enrolled in a state or federally government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card. Any claim under the Program must be submitted by participating pharmacies to one of the Administrators of the Program.

IMPORTANT SAFETY INFORMATION

Indication: EPSOLAY® (benzoyl peroxide) Cream, 5% is indicated for the treatment of inflammatory lesions of rosacea in adults. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with EPSOLAY Cream were pain, erythema (redness), pruritus (itching) and edema (swelling), all at the application site. Warnings/Precautions: Patients using EPSOLAY Cream may experience hypersensitivity reactions, including anaphylaxis (acute allergic reaction), angioedema (rapid swelling), and urticaria (hives). If serious hypersensitivity reaction occurs, discontinue use of EPSOLAY Cream immediately and seek medical attention/initiate appropriate therapy. Skin Irritation/contact dermatitis may be experienced, including erythema (redness), scaling, dryness, and stinging/burning. Irritation and contact dermatitis may occur. Use a moisturizer and discontinue EPSOLAY Cream if symptoms do not improve. Avoid application to cuts, abrasions, eczematous, or sunburned skin. EPSOLAY Cream may increase photosensitivity, sensitivity to ultraviolet light. Minimize or avoid exposure to natural or artificial sunlight (tanning beds or UVA/B treatment). Use sunscreen or protective clothing when sun exposure cannot be avoided. Discontinue use of EPSOLAY Cream at the first evidence of sunburn.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

IMPORTANT SAFETY INFORMATION

Indication: EPSOLAY® (benzoyl peroxide) Cream, 5% is indicated for the treatment of inflammatory lesions of rosacea in adults. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with EPSOLAY Cream were pain, erythema (redness), pruritus (itching) and edema (swelling), all at the application site. Warnings/Precautions: Patients using EPSOLAY Cream may experience hypersensitivity reactions, including anaphylaxis (acute allergic reaction), angioedema (rapid swelling), and urticaria (hives). If serious hypersensitivity reaction occurs, discontinue use of EPSOLAY Cream immediately and seek medical attention/initiate appropriate therapy. Skin Irritation/contact dermatitis may be experienced, including erythema (redness), scaling, dryness, and stinging/burning. Irritation and contact dermatitis may occur. Use a moisturizer and discontinue EPSOLAY Cream if symptoms do not improve. Avoid application to cuts, abrasions, eczematous, or sunburned skin. EPSOLAY Cream may increase photosensitivity, sensitivity to ultraviolet light. Minimize or avoid exposure to natural or artificial sunlight (tanning beds or UVA/B treatment). Use sunscreen or protective clothing when sun exposure cannot be avoided. Discontinue use of EPSOLAY Cream at the first evidence of sunburn.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

Stay connected

Sign up for updates about EPSOLAY cream and additional information about rosacea.

Please enter first name
Please enter last name
Please enter email
Please enter ZIP code
Please enter phone
Please choose
Please agree to the Terms of Use and Privacy Policy
By completing and submitting this form, you grant permission and agree to allow Galderma Laboratories, L.P., and its affiliates (“Galderma”) to collect the information you provide so that Galderma may market or advertise to you across multiple channels regarding EPSOLAY cream. Galderma will not sell or share this information with third parties. For additional information regarding how Galderma handles your information, please see our privacy policy. *Required. *Please enter the fields above.

Thank you for your interest in staying up to date on EPSOLAY cream.

Sign up for updates about EPSOLAY cream and additional information about rosacea.

HOME

Are you a healthcare professional?

The information contained in this section of the website is intended for US healthcare professionals only.